table of content
1 Introduction to Research & Analysis Reports
1.1 Pharmaceutical CDMO Solution Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pharmaceutical CDMO Solution Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pharmaceutical CDMO Solution Overall Market Size
2.1 Global Pharmaceutical CDMO Solution Market Size: 2023 VS 2030
2.2 Global Pharmaceutical CDMO Solution Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Pharmaceutical CDMO Solution Players in Global Market
3.2 Top Global Pharmaceutical CDMO Solution Companies Ranked by Revenue
3.3 Global Pharmaceutical CDMO Solution Revenue by Companies
3.4 Top 3 and Top 5 Pharmaceutical CDMO Solution Companies in Global Market, by Revenue in 2023
3.5 Global Companies Pharmaceutical CDMO Solution Product Type
3.6 Tier 1, Tier 2 and Tier 3 Pharmaceutical CDMO Solution Players in Global Market
3.6.1 List of Global Tier 1 Pharmaceutical CDMO Solution Companies
3.6.2 List of Global Tier 2 and Tier 3 Pharmaceutical CDMO Solution Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Pharmaceutical CDMO Solution Market Size Markets, 2023 & 2030
4.1.2 Active Pharmaceutical Ingredient (API) Manufacturing
4.1.3 Finished Dosage Formulation (FDF) Development and Manufacturing
4.1.4 Secondary Packaging
4.1.5 Others
4.2 By Type - Global Pharmaceutical CDMO Solution Revenue & Forecasts
4.2.1 By Type - Global Pharmaceutical CDMO Solution Revenue, 2019-2024
4.2.2 By Type - Global Pharmaceutical CDMO Solution Revenue, 2025-2030
4.2.3 By Type - Global Pharmaceutical CDMO Solution Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Pharmaceutical CDMO Solution Market Size, 2023 & 2030
5.1.2 Innovative Medicine
5.1.3 Patented Drug
5.1.4 Patent Expired Drug
5.1.5 Others
5.2 By Application - Global Pharmaceutical CDMO Solution Revenue & Forecasts
5.2.1 By Application - Global Pharmaceutical CDMO Solution Revenue, 2019-2024
5.2.2 By Application - Global Pharmaceutical CDMO Solution Revenue, 2025-2030
5.2.3 By Application - Global Pharmaceutical CDMO Solution Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Pharmaceutical CDMO Solution Market Size, 2023 & 2030
6.2 By Region - Global Pharmaceutical CDMO Solution Revenue & Forecasts
6.2.1 By Region - Global Pharmaceutical CDMO Solution Revenue, 2019-2024
6.2.2 By Region - Global Pharmaceutical CDMO Solution Revenue, 2025-2030
6.2.3 By Region - Global Pharmaceutical CDMO Solution Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Pharmaceutical CDMO Solution Revenue, 2019-2030
6.3.2 US Pharmaceutical CDMO Solution Market Size, 2019-2030
6.3.3 Canada Pharmaceutical CDMO Solution Market Size, 2019-2030
6.3.4 Mexico Pharmaceutical CDMO Solution Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Pharmaceutical CDMO Solution Revenue, 2019-2030
6.4.2 Germany Pharmaceutical CDMO Solution Market Size, 2019-2030
6.4.3 France Pharmaceutical CDMO Solution Market Size, 2019-2030
6.4.4 U.K. Pharmaceutical CDMO Solution Market Size, 2019-2030
6.4.5 Italy Pharmaceutical CDMO Solution Market Size, 2019-2030
6.4.6 Russia Pharmaceutical CDMO Solution Market Size, 2019-2030
6.4.7 Nordic Countries Pharmaceutical CDMO Solution Market Size, 2019-2030
6.4.8 Benelux Pharmaceutical CDMO Solution Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Pharmaceutical CDMO Solution Revenue, 2019-2030
6.5.2 China Pharmaceutical CDMO Solution Market Size, 2019-2030
6.5.3 Japan Pharmaceutical CDMO Solution Market Size, 2019-2030
6.5.4 South Korea Pharmaceutical CDMO Solution Market Size, 2019-2030
6.5.5 Southeast Asia Pharmaceutical CDMO Solution Market Size, 2019-2030
6.5.6 India Pharmaceutical CDMO Solution Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Pharmaceutical CDMO Solution Revenue, 2019-2030
6.6.2 Brazil Pharmaceutical CDMO Solution Market Size, 2019-2030
6.6.3 Argentina Pharmaceutical CDMO Solution Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Pharmaceutical CDMO Solution Revenue, 2019-2030
6.7.2 Turkey Pharmaceutical CDMO Solution Market Size, 2019-2030
6.7.3 Israel Pharmaceutical CDMO Solution Market Size, 2019-2030
6.7.4 Saudi Arabia Pharmaceutical CDMO Solution Market Size, 2019-2030
6.7.5 UAE Pharmaceutical CDMO Solution Market Size, 2019-2030
7 Pharmaceutical CDMO Solution Companies Profiles
7.1 Recipharm AB
7.1.1 Recipharm AB Company Summary
7.1.2 Recipharm AB Business Overview
7.1.3 Recipharm AB Pharmaceutical CDMO Solution Major Product Offerings
7.1.4 Recipharm AB Pharmaceutical CDMO Solution Revenue in Global Market (2019-2024)
7.1.5 Recipharm AB Key News & Latest Developments
7.2 Lonza Group
7.2.1 Lonza Group Company Summary
7.2.2 Lonza Group Business Overview
7.2.3 Lonza Group Pharmaceutical CDMO Solution Major Product Offerings
7.2.4 Lonza Group Pharmaceutical CDMO Solution Revenue in Global Market (2019-2024)
7.2.5 Lonza Group Key News & Latest Developments
7.3 Catalent
7.3.1 Catalent Company Summary
7.3.2 Catalent Business Overview
7.3.3 Catalent Pharmaceutical CDMO Solution Major Product Offerings
7.3.4 Catalent Pharmaceutical CDMO Solution Revenue in Global Market (2019-2024)
7.3.5 Catalent Key News & Latest Developments
7.4 Patheon (Thermo Fisher Scientific)
7.4.1 Patheon (Thermo Fisher Scientific) Company Summary
7.4.2 Patheon (Thermo Fisher Scientific) Business Overview
7.4.3 Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO Solution Major Product Offerings
7.4.4 Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO Solution Revenue in Global Market (2019-2024)
7.4.5 Patheon (Thermo Fisher Scientific) Key News & Latest Developments
7.5 Siegfried AG
7.5.1 Siegfried AG Company Summary
7.5.2 Siegfried AG Business Overview
7.5.3 Siegfried AG Pharmaceutical CDMO Solution Major Product Offerings
7.5.4 Siegfried AG Pharmaceutical CDMO Solution Revenue in Global Market (2019-2024)
7.5.5 Siegfried AG Key News & Latest Developments
7.6 SGS Quay Pharmaceuticals
7.6.1 SGS Quay Pharmaceuticals Company Summary
7.6.2 SGS Quay Pharmaceuticals Business Overview
7.6.3 SGS Quay Pharmaceuticals Pharmaceutical CDMO Solution Major Product Offerings
7.6.4 SGS Quay Pharmaceuticals Pharmaceutical CDMO Solution Revenue in Global Market (2019-2024)
7.6.5 SGS Quay Pharmaceuticals Key News & Latest Developments
7.7 Curia
7.7.1 Curia Company Summary
7.7.2 Curia Business Overview
7.7.3 Curia Pharmaceutical CDMO Solution Major Product Offerings
7.7.4 Curia Pharmaceutical CDMO Solution Revenue in Global Market (2019-2024)
7.7.5 Curia Key News & Latest Developments
7.8 Societal CDMO
7.8.1 Societal CDMO Company Summary
7.8.2 Societal CDMO Business Overview
7.8.3 Societal CDMO Pharmaceutical CDMO Solution Major Product Offerings
7.8.4 Societal CDMO Pharmaceutical CDMO Solution Revenue in Global Market (2019-2024)
7.8.5 Societal CDMO Key News & Latest Developments
7.9 Aenova Group
7.9.1 Aenova Group Company Summary
7.9.2 Aenova Group Business Overview
7.9.3 Aenova Group Pharmaceutical CDMO Solution Major Product Offerings
7.9.4 Aenova Group Pharmaceutical CDMO Solution Revenue in Global Market (2019-2024)
7.9.5 Aenova Group Key News & Latest Developments
7.10 Eurofins CDMO
7.10.1 Eurofins CDMO Company Summary
7.10.2 Eurofins CDMO Business Overview
7.10.3 Eurofins CDMO Pharmaceutical CDMO Solution Major Product Offerings
7.10.4 Eurofins CDMO Pharmaceutical CDMO Solution Revenue in Global Market (2019-2024)
7.10.5 Eurofins CDMO Key News & Latest Developments
7.11 Piramal Group
7.11.1 Piramal Group Company Summary
7.11.2 Piramal Group Business Overview
7.11.3 Piramal Group Pharmaceutical CDMO Solution Major Product Offerings
7.11.4 Piramal Group Pharmaceutical CDMO Solution Revenue in Global Market (2019-2024)
7.11.5 Piramal Group Key News & Latest Developments
7.12 WuXi AppTec Group
7.12.1 WuXi AppTec Group Company Summary
7.12.2 WuXi AppTec Group Business Overview
7.12.3 WuXi AppTec Group Pharmaceutical CDMO Solution Major Product Offerings
7.12.4 WuXi AppTec Group Pharmaceutical CDMO Solution Revenue in Global Market (2019-2024)
7.12.5 WuXi AppTec Group Key News & Latest Developments
7.13 Fareva
7.13.1 Fareva Company Summary
7.13.2 Fareva Business Overview
7.13.3 Fareva Pharmaceutical CDMO Solution Major Product Offerings
7.13.4 Fareva Pharmaceutical CDMO Solution Revenue in Global Market (2019-2024)
7.13.5 Fareva Key News & Latest Developments
7.14 Strides Pharma Science
7.14.1 Strides Pharma Science Company Summary
7.14.2 Strides Pharma Science Business Overview
7.14.3 Strides Pharma Science Pharmaceutical CDMO Solution Major Product Offerings
7.14.4 Strides Pharma Science Pharmaceutical CDMO Solution Revenue in Global Market (2019-2024)
7.14.5 Strides Pharma Science Key News & Latest Developments
7.15 Famar Health Care Service
7.15.1 Famar Health Care Service Company Summary
7.15.2 Famar Health Care Service Business Overview
7.15.3 Famar Health Care Service Pharmaceutical CDMO Solution Major Product Offerings
7.15.4 Famar Health Care Service Pharmaceutical CDMO Solution Revenue in Global Market (2019-2024)
7.15.5 Famar Health Care Service Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
